Zidong Lu, PhD - Publications
Affiliations: | 2012-2016 | Institute of Pharmaceutical Science | King's College London, London, UK |
2016- | School of Medicine | South China University of Technology |
Area:
nanomedicine, iron chelator, gene delivery, drug deliveryWebsite:
https://www2.scut.edu.cn/lifesciences/2018/0111/c15050a250483/page.htmYear | Citation | Score | |||
---|---|---|---|---|---|
2020 | Chen W, Yuan X, Li Z, Lu Z, Kong S, Jiang H, Du H, Pan X, Nandi M, Kong X, Brown K, Liu Z, Zhang G, Hider RC, Yu Y. CN128, a new orally active hydroxypyridinone iron chelator. Journal of Medicinal Chemistry. PMID 32208614 DOI: 10.1021/Acs.Jmedchem.0C00137 | 0.578 | |||
2016 | Xie YY, Lu Z, Kong XL, Zhou T, Bansal S, Hider R. Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone. European Journal of Medicinal Chemistry. 115: 132-140. PMID 27014847 DOI: 10.1016/J.Ejmech.2016.03.014 | 0.445 | |||
2015 | Li J, Lu Z, Kong X, Ma Y, Zhang X, Bansal SS, Abbate V, Hider RC. Design and synthesis of novel pegylated iron chelators with decreased metabolic rate. Future Medicinal Chemistry. 7: 2439-49. PMID 26670054 DOI: 10.4155/Fmc.15.154 | 0.481 | |||
Show low-probability matches. |